Form 4: Aspira Women's Health Director Winfred Parnell Reports Stock Transaction

Director Winfred Parnell reported the vesting and acquisition of 15,803 shares of Aspira Women's Health Inc. common stock on August 12, 2024, followed by a disposal of shares.

Summary

• On August 12, 2024, Winfred Parnell, a director of Aspira Women's Health Inc., acquired 15,803 shares of common stock.
• These shares were obtained through the vesting of restricted stock units (RSUs), each convertible to one share of common stock.
• The RSUs vested fully on August 12, 2024.
• Following the acquisition, Parnell disposed of 50,584 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in Winfred Parnell's ownership of Aspira Women's Health Inc. stock.

Stakeholder Impact

• The transaction may be of interest to shareholders as it reflects changes in insider ownership.

Key Dates

Keywords

Aspira Women's Health Inc., Winfred Parnell, Director, Form 4, Stock Transaction, Restricted Stock Units, Vesting, Common Stock, Beneficial Ownership